Clinical Trial Update: Effect of a Parenteral Emulsion With Omega3 on Neonates With PPHN and CDH [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a parenteral omega-3 emulsion in newborns with pulmonary hypertension of the newborn and diaphragmatic defects; enrollmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Diaphragmatic Hernia
• Pulmonary Hypertension of the Newborn

Drugs mentioned

• Parenteral omega-3 emulsion (omega-3 fatty acid emulsion)

Snippet

Sponsor: Coordinación de Investigación en Salud, Mexico | Conditions: Pulmonary Hypertension of Newborn, Diaphragm Defect | Phase 2 | Status: ENROLLING_BY_INVITATION